DTx Podcast with Eugene Borukhovich

In this episode, we hear from Ali Hashemi, Co-founder of meta[bolic]. In their own words, meta[bolic] is a hybrid digital therapeutics company focused on addressing the global metabolic health crisis. In this episode, we cover: The initial business hypothesis of GluCare and meta[bolic] Digital therapeutics vs disease management Why we are becoming more metabolically unstable than previous generati...

In this episode we kick off the next chapter of the DTx podcast. We heard you loud and clear - this industry is here to stay and therefore we are moving away from Seasons and going Evergreen - so what does that mean for you? It means we will continue bringing you deep conversations and knowledge from trailblazers, policy makers, associations and of course patients and health consumers. Chandana Fi...

In this episode, we hear from Louisa Stuwe & Aymeric Perchant, eHealth projects directors at the French Ministry of Health. For those who follow this podcast and the digital therapeutics industry, you know that all eyes have been on Germany with the DiGA. Well by popular demand, I have the pleasure of hosting Louisa and Aymeric to give YOU, our audience, a bit of history and the current state of d...

In this episode, we hear from Shailja Dixit, CEO of Curio. In their own words: 'Curio is a Digital Therapeutics company with tailor-made Cognitive Behavioral Therapy programs for Women across the cycle of life – encompassing age groups, physiological conditions and social settings'. Topics include: The Founding Story of Curio Using Digital to Destigmatize Mental Health Support User experience of t...

In this episode, we hear from Dominik Burziwoda, CEO and Co-Founder of Perfood. Perfood, in their own words is working on a pipeline of 'prescription digital therapeutics powered by personalized nutrition'. In this episode, we cover: The background and creation of Perfood The digital health scene in Germany Consumer experience of Perfood The process of DiGA approval and commercialisation Guest Lin...

In this episode, we hear from Clara Campàs, Managing Partner and Co-Founder at Asabys Partners. Asabys Partners is an venture fund based in Barcelona, Spain investing in healthcare and life sciences innovation. In this episode, we cover: The healthcare thesis at Asabys Ventures Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx + Approaching valuations and investments when entering the DTx spa...

In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions at the time of a clinical decision. We'll explore the major pain points that keep projects from reaching their full potential, what it takes to overcome these challenges and what you can do when you're developing a digital therapeutic solution for yo...

In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases. In this episode, we cover: How Orion approaches non-molecular innovation Solving misconceptions in digital medicine...

In this episode we hear from Sai Shankar, President of the Digital Health Unit at Aptar Pharma. Aptar Pharma provides drug delivery systems, active material science solutions and services globally- some products include: nasal spray pumps, MDI valves, dose indicators & counters, DPIs, electronic / connected devices, eye-droppers, elastomeric components (for injectable delivery devices), and more!...

In this episode, we hear from Francesca Wuttke, Founder and CEO of Nen who is focusing on building prescription digital therapeutic at a cross-section of pediatrics, pain with an initial focus in oncology. In this episode, we cover: The background to nen and naming the company Gamifying CBT for treating children's pain Targeting the psychological aspects of pain Treating unmet needs in oncology Pa...

In this episode I speak with Seth Feuerstein, Founder and CEO of Oui therapeutics, a digital therapeutic company that recently came out of stealth. In their own words: Oui is purpose built to tackle suicide and other challenging health care problems. In this episode, we cover: The background and funding journey to creating Oui What are the existing options for suicide prevention? What is the patie...

In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base. In this episode, we cover: New company creation: large company spin-outs vs entrepreneurs  What it takes to build a team that can take a digital therapeutic to market Why build rather than buy a new DTx...

In this episode, we hear from Meg Barron, Vice President of Digital Health Strategy at the American Medical Association, which represents the voices of over ¼ million physicians and is the largest and only national association that convenes 190+ state and specialty medical societies and other critical stakeholders In this episode, we cover: AMA’s position on digital health- how do we help to make...

Today, I speak with Mark Bini, Vice President of Pharmacy Care Solutions at Evernorth - Cigna’s health services arm which spearheaded a digital health formulary which includes companies such as Omada, QuitGenious and Hinge Health  In this episode, we cover: The history and evolution of Evernorth How Evernorth works with it's parent Cigna colleagues What it takes for a DTx to be part of the formula...

In this episode we hear from Steve Driver, the Medical Director of Digital Therapeutics at one of the largest health systems in the US, Advocate Aurora Health. I have been itching to get a view from a health system perspective on this show since season one. As a practicing cardiologist, it is always great to hear from somebody who is practicing this in the front lines.  We cover:  The expectations...

In this episode we jumped right into the drug+ discussion with Pamela Stahl, Chief Commercial Officer at Sidekick Health. In their own words Sidekick health is all about “Gamified digital therapeutics built on science, rooted in behavioral economics, and scalable across multiple therapeutic areas.” In this episode, we cover: The origin of Sidekick Health and what led Tryggvi to start the company T...

In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa. In their owns words, “Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable access to care and improving the lives and outcomes of children and families living with behavio...

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden. Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcar...

Gut-directed hypnotherapy has an ability to retrain both nervous systems to work together to communicate better, giving the central nervous system the ability to downregulate the hyper vigilant signals that are being sent up from the enteric nervous system. Despite there being over 20 different randomized controlled trials showing that gut directed hypnotherapy has a positive impact on all of the...

Biofourmis is not your typical standalone DTx company! On the heels of a $300M round, Biofourmis has evolved to a full data driven healthcare services organization with a strong foundation of digital therapies driving care decisions. To learn more about their work and plans for the future, I went straight to Kuldeep Singh Rajput, founder and CEO of Biofourmis. Biofourmis, in their own words, “util...

Cognitive behavioral therapy (CBT) is an evidence-based form of therapy that has been in use for decades. My guest in this episode believes that CBT can be applied to create better therapeutics, and, in fact, that's exactly what his company is called: Better Therapeutics. Dr. Mark Berman, the Chief Medical Officer at Better Therapeutics, explained that the goal of CBT is to "help people change som...

Everyone knows it's important to get a good night's sleep, but what if nightmares are keeping you aware? Frequent nightmares can disrupt your sleep, cause stress and interfere with your ability to function during the day. A diagnosis of "nightmare disorder" can occur if disturbing dreams cause stress and keep someone from getting enough sleep.(1) This episode features Grady Hannah, co-founder and...

The association between music and medicine has been discussed for decades, and the development of music therapy has been shown to improve outcomes for patients of all ages, and from the immune system to the mind. To tell us more about how music can play a role in digital therapeutics, we hear from Brian Harris, the Co-founder and CEO of MedRhythms. MedRhythms is a digital therapeutics company focu...

Join me for this conversation with M. Jason Brooke, MSE, JD, CSQE, Attorney and Managing Member of Brooke Consulting LLC. Brooke Consulting is a digital health legal and regulatory advisory firm. Jason offers a unique, multi-disciplinary perspective on the digital health industry as a regulatory attorney, scientist, technologist, and quality consultant. Jason and I talk about the three main pathwa...

In this episode, we hear from Mike Pace, Founder & CEO of PalmHealthco. PalmHealthco provides market access, commercialization, evidence generation and go-to-market executive advisory and strategic consulting services to digital health, biopharmaceutical and medical device firms around the world.  Mike and I talk about the differences in going to market and the commercial pathways for biopharmaceu...